AxoSim 2022 Year in Review
News and BlogAxoSim’s 2022 Year in Review publication highlights company achievements, technology highlights and goals moving into 2023. View the full report featuring Q&As with our scientists below. Read Report
Read MoreAxoSim’s 2022 Year in Review publication highlights company achievements, technology highlights and goals moving into 2023. View the full report featuring Q&As with our scientists below. Read Report
Read MoreRead Article in The Times-Picayune | Nola.com AxoSim and New Orleans BioInnovation Center Celebrate Lab Expansion The new space will provide 2,000 more square feet for AxoSim research in the heart of the BioDistrict NEW […]
Read MoreAxoSim is honored to welcome Edward “Ted” Spack, PhD, as its new Executive Director of Research and Development. Ted brings more than 30 years of start-up biotech experience, including co-founding a biotech and mentoring local […]
Read MoreMeet us at SOT 2023 | March 19-23 2023 | Nashville, TN We will be on the road for the SOT 2023 Annual Meeting in Nashville, TN. We are excited to have two poster presentations […]
Read MoreDear AxoSim Supporters, This year has been one of amazing progress both for AxoSim and for our entire industry. We have seen our largest year of growth and technology adoption, both across our large biopharma […]
Read MoreThe AxoSim Team will be on the road for the Society of Neuroscience 2022 Annual Meeting in San Diego, CA. We are excited to have two poster presentations and our CEO Lowry Curley, PhD, will […]
Read MoreMeet AxoSim Research Scientist Lise Harbom, PhD Tell us about yourself. I attended Vanderbilt University for undergraduate studies where I double majored in Neuroscience and French. I also graduated with honors in Neuroscience, completing an […]
Read MoreCheck out AxoSim CEO Lowry Curley PhD, and Obatala Sciences CEO Trivia Frazier’s, PhD, MBA, op-ed highlighting their experiences growing companies in Southeast Louisiana and how important funding is for the BioDistrict for future growth and success. Nola.com Letters: BioDistrict will […]
Read MoreDear Colleagues and Friends, 2022 has been busy and productive for all of us on the AxoSim team. In particular, we have made great progress on our strategic focus for 2022, our NerveSim® peripheral neuropathy […]
Read MoreCheck out The Tech Tribune’s Q&A piece with our Co-Founder Michael J. Moore, PhD. AxoSim is honored to be featured three years running as one of Tech Tribune’s best start ups in Louisiana. Tell us […]
Read More